Thrombophilia screening tested the presence of factor V Leiden, G20210A prothrombin gene mutation, antiphospholipid antibodies, factor VII, protein C, protein S and antithrombin activities. This evidence concerns the gene PROS1 and Rare hereditary thrombophilia.